{"name":"Pharmbio Korea Co., Ltd.","slug":"pharmbio-korea-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"OST","genericName":"OST","slug":"ost","indication":"Treatment of osteoporosis in postmenopausal women and men","status":"marketed"},{"name":"Oral Sulfate Tablet 2-Day","genericName":"Oral Sulfate Tablet 2-Day","slug":"oral-sulfate-tablet-2-day","indication":"Constipation","status":"phase_3"},{"name":"PBK_M2101 2-Day","genericName":"PBK_M2101 2-Day","slug":"pbk-m2101-2-day","indication":"Phase 3 clinical trial for a specific indication","status":"phase_3"},{"name":"PBK_M2502 1-Day","genericName":"PBK_M2502 1-Day","slug":"pbk-m2502-1-day","indication":"unknown","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"PBK_L2201","genericName":"PBK_L2201","slug":"pbk-l2201","indication":"Type 2 diabetes","status":"phase_3"},{"name":"PBK-1701TC","genericName":"PBK-1701TC","slug":"pbk-1701tc","indication":"Type 2 diabetes","status":"phase_3"},{"name":"PBK_M2101 1-Day","genericName":"PBK_M2101 1-Day","slug":"pbk-m2101-1-day","indication":"Type 2 diabetes","status":"phase_3"},{"name":"PBK_M2502 2-Day","genericName":"PBK_M2502 2-Day","slug":"pbk-m2502-2-day","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"OST","genericName":"OST","slug":"ost","phase":"marketed","mechanism":"OST is an osteoclast inhibitor.","indications":["Treatment of osteoporosis in postmenopausal women and men","Treatment of glucocorticoid-induced osteoporosis"],"catalyst":""},{"name":"PBK_L2201","genericName":"PBK_L2201","slug":"pbk-l2201","phase":"phase_3","mechanism":"PBK_L2201 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Oral Sulfate Tablet 2-Day","genericName":"Oral Sulfate Tablet 2-Day","slug":"oral-sulfate-tablet-2-day","phase":"phase_3","mechanism":"Oral sulfate acts as an osmotic laxative that draws water into the intestinal lumen to promote bowel evacuation.","indications":["Constipation","Bowel preparation"],"catalyst":""},{"name":"PBK-1701TC","genericName":"PBK-1701TC","slug":"pbk-1701tc","phase":"phase_3","mechanism":"PBK-1701TC is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"PBK_M2101 1-Day","genericName":"PBK_M2101 1-Day","slug":"pbk-m2101-1-day","phase":"phase_3","mechanism":"PBK_M2101 1-Day is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"PBK_M2101 2-Day","genericName":"PBK_M2101 2-Day","slug":"pbk-m2101-2-day","phase":"phase_3","mechanism":"PBK_M2101 2-Day is a small molecule that targets the molecular target.","indications":["Phase 3 clinical trial for a specific indication"],"catalyst":""},{"name":"PBK_M2502 1-Day","genericName":"PBK_M2502 1-Day","slug":"pbk-m2502-1-day","phase":"phase_3","mechanism":"PBK_M2502 1-Day is a small molecule drug that targets the molecular target.","indications":["unknown"],"catalyst":""},{"name":"PBK_M2502 2-Day","genericName":"PBK_M2502 2-Day","slug":"pbk-m2502-2-day","phase":"phase_3","mechanism":"PBK_M2502 2-Day is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQWkpvT1pGOEZIN0RGUzBYSnIySUVXZ1ZwSktrM3RIZVRTMTJzMHB4QnhSb3JKUTBaTDhTS2lNRWdrLVBJY0lWVG84NzVKZHBSWUZER0NKWVhpbnlucjJxMzVDbnc0ZGRUbmk0VHM3aEZOZ1RzSDZLaUItZEZBb0V4ddIBlAFBVV95cUxQb0lDODZPemhRVkhZWHd2bXBMSVZQYXp6Ukx0TXAxTGZCb2Zmb3VoOExEbjdzYlRsUTQzT3VTT3BpQWNRMWVEeXZUWTJ1MG1fUlBBczFWVFdIQ3N0ZlpvLS1vQXdPUFo4dnUwSDlGRTVSR2FNa3RsdjFSUWl6eldFbUZNRGxVRzV3c1U1Qk9wVjN0RVBU?oc=5","date":"2026-04-06","type":"pipeline","source":"Chosunbiz","summary":"Korea pharma shifts to external hires as price cuts push global R&D - CHOSUNBIZ - Chosunbiz","headline":"Korea pharma shifts to external hires as price cuts push global R&D - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQb0lDODZPemhRVkhZWHd2bXBMSVZQYXp6Ukx0TXAxTGZCb2Zmb3VoOExEbjdzYlRsUTQzT3VTT3BpQWNRMWVEeXZUWTJ1MG1fUlBBczFWVFdIQ3N0ZlpvLS1vQXdPUFo4dnUwSDlGRTVSR2FNa3RsdjFSUWl6eldFbUZNRGxVRzV3c1U1Qk9wVjN0RVBU0gGUAUFVX3lxTFBvSUM4Nk96aFFWSFlYd3ZtcExJVlBhenpSTHRNcDFMZkJvZmZvdWg4TERuN3NiVGxRNDNPdVNPcGlBY1ExZUR5dlRZMnUwbV9SUEFzMVZUV0hDc3RmWm8tLW9Bd09QWjh2dTBIOUZFNVJHYU1rdGx2MVJRaXp6V0VtRk1EbFVHNXdzVTVCT3BWM3RFUFQ?oc=5","date":"2026-04-06","type":"pipeline","source":"Chosunbiz","summary":"Korea pharma shifts to external hires to power R&D and global expansion - CHOSUNBIZ - Chosunbiz","headline":"Korea pharma shifts to external hires to power R&D and global expansion - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOSHBhMEZtdVNFbkd1cnVzTnI5Z1h3OEpWSXBpcTZrcHpqdW9ZMm1NRDZZYmlQYVVrNEFtNTRPNFRDSDlpMFlNLWtlMllpMF81QUZRQ2pvcXQ0emlYbXVzVDBVZEJ3TjUtRzlHWVM3UExnUFpBT085ZFc0d0NmbHJ0ck4tTGRiVFc4cHRjSEI4OXVTZVBtc3VJSUdpU2FaU1UzaXVweEtIcWFFX0lGbGpnWlFmM1Ntdw?oc=5","date":"2025-04-12","type":"pipeline","source":"BioSpectrum Asia","summary":"KOREA PHARM & BIO 2025 to showcase next-generation biotechnologies - BioSpectrum Asia","headline":"KOREA PHARM & BIO 2025 to showcase next-generation biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBKRHgxZ01YSDdGSEJTVEFvSlp6MC1obnlXQkFQVUN4WFpYWVh0Zk9hTzJQalliQmVTZ0c0aWh3NjZ4dlJQZmU5SkV0OHNIaXUzbDNnVk1aMkotWlBKUUJtWWxvd2hmSEVHRGsyWUhB0gFyQVVfeXFMTy10am93c0oxREp5YWlBenI1SlVJRmdKdVFkUFhMOUs4SG5TQ2d4VkxWQ3JET0JRUlZjYmctallwM3ZCYndsenlUQjFzUnlJZnhfNU9LQ0ZuYU1fdEJDdm5RcU1jTGFPaWJiRXE4YXJhR1NB?oc=5","date":"2022-07-07","type":"pipeline","source":"koreabiomed.com","summary":"Pharmbio Korea to supply Canada-made AGHD drug - koreabiomed.com","headline":"Pharmbio Korea to supply Canada-made AGHD drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOUkRsY01EVUNVYzQzbGMySGVXNlZiSUFxYmZaNGI5NjFTSE51VVFWN0NVb2lBemRqdXVTdVRvOUZNZktoU21wMTExMFRRRlozSzBEZmxiazZISFVkcDVoQ2RJa2JsSnVPMjJqcldweS0zVVlSdVVyWExHb3pzSVFQa2NiUFBxcWRRcmNfdWh1NS1DUjVpYm9MY2pwQktxU283VDFuTkxmckpDYzl4d0FIV2M0djFfdWs4dldTclBGUzZYYWsxdkZjTjRhSXg?oc=5","date":"2022-06-08","type":"pipeline","source":"GlobeNewswire","summary":"Radius Health Expands Non-US Market Footprint for TYMLOS - GlobeNewswire","headline":"Radius Health Expands Non-US Market Footprint for TYMLOS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1lSzEtcTBFOUhNRUt4Y2czMUE1WkdSRW8zMmJ0UHJ0aWh5TzdEYjB3UXRfeFBTOHJKQnZQWXBWLVhHcnp2MFJLVTl1bXRYSjhhV2c5RkRmWk1RR05rQnY0UFUxbEc4Z3lfcnluNdIBcEFVX3lxTFB6VElvemJTU0pXY2Y4WS1ySjRrRHlSTUFjcUpwZUpLc01FSFcxOFNYYzhkbW5ER1VuTldDQVJzRjl3eG9FdWpJZGhzRUowQTZpcXpvVV9DQ3V4QldKMUhDUGJOOXhrRnAzNTJUcktUdkY?oc=5","date":"2018-07-09","type":"pipeline","source":"koreabiomed.com","summary":"Pharmbio to enter Mongol’s colonoscopy market - koreabiomed.com","headline":"Pharmbio to enter Mongol’s colonoscopy market","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"marketed":1,"phase_3":7},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}